stars 1 stars 2 stars 3

Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated on atrasentan, zigakibart and the rest of the Chinook pipeline. For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics

View Top Employees from Chinook Therapeutics, Inc.
Website http://www.chinooktx.com/
Ticker KDNY
Revenue $2 million
Funding $171 million
Employees 255 (255 on RocketReach)
Founded 2019
Phone (510) 848-4400
Technologies
Industry Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare
SIC SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies
NAICS NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies

Chinook Therapeutics, Inc. Questions

The Chinook Therapeutics, Inc. annual revenue was $2 million in 2024.

Tom Frohlich is the COO of Chinook Therapeutics, Inc..

255 people are employed at Chinook Therapeutics, Inc..

Chinook Therapeutics, Inc. is based in Seattle, Washington.

The NAICS codes for Chinook Therapeutics, Inc. are [325, 3254, 32541, 32].

The SIC codes for Chinook Therapeutics, Inc. are [283, 28, 2834].

Top Chinook Therapeutics, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users